A study published in JAMA Internal Medicine has found that Januvia and Byetta, two popular GLP-1 therapies used for the treatment of diabetes, may greatly increase the risk of pancreatitis. The FDA flagged Byetta for pancreatitis in 2007 and … [Read more...]
New Warnings to be Added to Labels of Cholesterol Lowering Drugs
The FDA announced they will be adding labels to cholesterol lowering drugs, such as Lipitor, to indicate a possibility of raising blood sugar levels and causing memory loss. Statins including Lipitor, Crestor, and Zocor have shown their benefits in … [Read more...]